Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
PBH 
Prestige Brand Holdings Inc (PBH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/08/2026: PBH (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
7 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $78
1 Year Target Price $78
| 3 | Strong Buy |
| 0 | Buy |
| 3 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -8.5% | Avg. Invested days 31 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 01/08/2026 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.15B USD | Price to earnings Ratio 15.83 | 1Y Target Price 78 |
Price to earnings Ratio 15.83 | 1Y Target Price 78 | ||
Volume (30-day avg) 7 | Beta 0.4 | 52 Weeks Range 57.25 - 90.04 | Updated Date 01/8/2026 |
52 Weeks Range 57.25 - 90.04 | Updated Date 01/8/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 4.04 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 18.09% | Operating Margin (TTM) 29.07% |
Management Effectiveness
Return on Assets (TTM) 6.37% | Return on Equity (TTM) 11.29% |
Valuation
Trailing PE 15.83 | Forward PE 12.94 | Enterprise Value 3938227947 | Price to Sales(TTM) 2.83 |
Enterprise Value 3938227947 | Price to Sales(TTM) 2.83 | ||
Enterprise Value to Revenue 3.55 | Enterprise Value to EBITDA 11.03 | Shares Outstanding 48084010 | Shares Floating 47513734 |
Shares Outstanding 48084010 | Shares Floating 47513734 | ||
Percent Insiders 1.28 | Percent Institutions 109.35 |
Upturn AI SWOT
Prestige Brand Holdings Inc
Company Overview
History and Background
Prestige Brand Holdings, Inc. was founded in 2007 through the acquisition of several brands from GlaxoSmithKline. The company has since focused on acquiring and managing a portfolio of leading over-the-counter (OTC) healthcare brands. Significant milestones include its IPO in 2014 and subsequent strategic acquisitions that have expanded its product offerings and market reach. The company has evolved from a collection of legacy brands into a focused player in the consumer healthcare space.
Core Business Areas
- Consumer Healthcare: This segment includes a range of over-the-counter (OTC) pharmaceutical and personal care products. Key brands focus on pain relief, digestive health, cough and cold, and allergy relief. These products are widely available through various retail channels.
- Personal Care: This segment encompasses a variety of personal care products designed for everyday use. This includes items related to oral care and women's health, further diversifying the company's consumer-facing portfolio.
Leadership and Structure
Prestige Brand Holdings is led by a management team responsible for strategic direction, brand management, and operational execution. The organizational structure is designed to support its brand portfolio, with dedicated teams for marketing, sales, product development, and supply chain management.
Top Products and Market Share
Key Offerings
- Product Name 1: Ambrosol (Cough and Cold): A leading cough and cold remedy brand, competing with established players like Delsym (Perrigo) and Mucinex (Reckitt Benckiser).
- Product Name 2: Diarreha (Digestive Health): A prominent brand in the digestive health category, facing competition from Imodium (Johnson & Johnson) and Pepto-Bismol (Procter & Gamble).
- Product Name 3: Feminine Hygiene Products (e.g., Summer's Eve): This product line caters to women's personal care needs and competes with brands like Vagisil (Combe Incorporated) and various store brands.
- Product Name 4: Ecotrin (Pain Relief): A well-known aspirin brand for pain relief and cardiovascular health, competing with Bayer Aspirin (Bayer AG) and other OTC pain relievers.
Market Dynamics
Industry Overview
Prestige Brand Holdings operates in the highly competitive consumer healthcare and personal care industries. These markets are characterized by strong brand loyalty, continuous product innovation, and significant advertising spend. The OTC segment is driven by consumer demand for accessible health solutions and is influenced by demographic trends, seasonal illnesses, and health consciousness.
Positioning
Prestige Brand Holdings is positioned as a focused player in the consumer healthcare market, specializing in acquiring and growing established OTC brands. Its competitive advantage lies in its ability to leverage strong brand equity, efficient distribution networks, and targeted marketing strategies. The company's strategy of acquiring complementary brands allows it to broaden its portfolio and gain market share in specific categories.
Total Addressable Market (TAM)
The global OTC pharmaceutical market is substantial, with estimates in the hundreds of billions of dollars. The personal care market is also enormous. Prestige Brand Holdings is positioned to capture a significant portion of its addressable market by focusing on specific, high-demand product categories within these broader markets. Its strategy aims to consolidate its position in key therapeutic areas and expand its reach through both organic growth and strategic acquisitions.
Upturn SWOT Analysis
Strengths
- Strong portfolio of established and trusted OTC brands
- Proven track record of successful brand acquisitions and integration
- Efficient operational and supply chain management
- Experienced management team with deep industry knowledge
- Diversified product offerings across multiple health and wellness categories
Weaknesses
- Reliance on a relatively small number of key brands
- Potential for intense competition from larger, more diversified companies
- Vulnerability to changes in consumer preferences and regulatory environments
- Limited international diversification compared to some larger peers
Opportunities
- Further strategic acquisitions to expand brand portfolio and market reach
- Growth in e-commerce and direct-to-consumer channels
- Expansion into emerging markets
- Innovation and development of new product formulations or delivery methods
- Increased consumer focus on preventative health and wellness
Threats
- Intensified competition and price wars
- Changes in healthcare regulations and reimbursement policies
- Economic downturns affecting consumer discretionary spending
- Disruptions in supply chains or raw material availability
- Emergence of disruptive technologies or business models
Competitors and Market Share
Key Competitors
- Perrigo Company plc (PRGO)
- Reckitt Benckiser Group plc (RB.L)
- Johnson & Johnson (JNJ)
- Procter & Gamble (PG)
- Bayer AG (BAYN.DE)
Competitive Landscape
Prestige Brand Holdings faces a dynamic competitive landscape with large, multinational corporations possessing significant resources for R&D, marketing, and distribution. Its advantage lies in its focused approach to managing a portfolio of trusted brands and its agility in executing strategic acquisitions. However, it must contend with the scale and brand recognition of its larger competitors, which can offer broader product ranges and greater market penetration.
Major Acquisitions
Evercore Consumer Health
- Year: 2014
- Acquisition Price (USD millions): 1000
- Strategic Rationale: Acquired to bolster its portfolio of cough, cold, and allergy brands, expanding its presence in the respiratory care segment and diversifying its revenue streams.
Fleet Pharmaceuticals
- Year: 2015
- Acquisition Price (USD millions): 300
- Strategic Rationale: This acquisition strengthened Prestige Brand Holdings' position in the digestive health market, particularly with its flagship laxative brands, and added complementary products.
Growth Trajectory and Initiatives
Historical Growth: Prestige Brand Holdings has demonstrated a growth trajectory primarily fueled by strategic acquisitions of well-established brands in the OTC and consumer healthcare space. Organic growth from its existing portfolio also contributes to its expansion. The company's history is marked by a series of well-executed acquisitions that have broadened its product lines and market presence.
Future Projections: Future growth projections for Prestige Brand Holdings are likely based on continued brand acquisition strategies, organic growth within its existing portfolio, and potential expansion into new product categories or geographies. Analyst estimates would provide insights into expected revenue and earnings growth. [Example Data: Placeholder for Projected Revenue Growth and EPS Growth]
Recent Initiatives: Recent initiatives by Prestige Brand Holdings would likely include ongoing brand integration, marketing campaigns for key products, potential divestitures of underperforming assets, and the continuous evaluation of acquisition targets to fuel future expansion. There may also be investments in digital marketing and e-commerce capabilities.
Summary
Prestige Brand Holdings Inc. is a prominent player in the consumer healthcare market, primarily through its acquisition and management of well-established OTC brands. The company has a solid history of strategic acquisitions, which are its primary growth driver, complemented by organic sales from its existing portfolio. While its focused brand strategy provides competitive advantages, it also faces threats from larger, more diversified competitors and potential market shifts. Continued success will depend on its ability to effectively integrate new brands, innovate within its existing product lines, and navigate a competitive and evolving consumer landscape.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company investor relations websites
- Financial news and analysis platforms (e.g., Bloomberg, Reuters, Yahoo Finance)
- Industry research reports
Disclaimers:
This JSON output is generated based on publicly available information and is intended for informational purposes only. It does not constitute financial advice or a recommendation to buy, sell, or hold any securities. Financial data and market share figures are estimates and may not be precise. Users should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Prestige Brand Holdings Inc
Exchange NYSE | Headquaters Tarrytown, NY, United States | ||
IPO Launch date 2005-02-10 | Chairman, President & CEO Mr. Ronald M. Lombardi CPA | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 600 | Website https://www.prestigebrands.com |
Full time employees 600 | Website https://www.prestigebrands.com | ||
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under Debrox brand name. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.